SCENESSE® European Orphan Drug Designation for Variegate Porphyria 2024 Announcements.Clinical.News 24.06.2024
Technical note: Afamelanotide as MC1R-targeted therapy in Parkinson’s [PD] 2024 Announcements . Clinical . News 18.06.2024
CLINUVEL withdraws SCENESSE® label expansion for adolescent erythropoietic protoporphyria 2024 Announcements . Clinical . News 03.06.2024
CLINUVEL and Valentech enter SCENESSE® LATAM partnership 2024 Announcements . Financial . News . Regulatory 23.05.2024